9/24/24 21:01 | 9/23/24 | ROIV | Roivant Sciences Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Gline Matthew | X0 | DO | CEO | M.d | 5,968 | 3.85 | 0 | 1,550 | 10 | 17,372 | D | | | | | | | | | | | | | | |
9/24/24 21:01 | 9/23/24 | ROIV | Roivant Sciences Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Gline Matthew | X0 | DO | CEO | S.d | -23,383 | 11.79 | 0 | -1,983 | -10 | 17,372 | D | | | | | | | | | | | | | | |
4/2/24 21:00 | 3/30/24 | ROIV | Roivant Sciences Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Gline Matthew | X0 | DO | CEO | M.d | 0 | 0.00 | 0 | 391 | 50 | 1,165 | D | | | | | | | | | | | | | | |
12/29/23 21:00 | 12/27/23 | ROIV | Roivant Sciences Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Gline Matthew | X0 | DO | CEO | M.d | 0 | 0.00 | 0 | 38 | 4 | 1,023 | D | | | | | | | | | | | | | | |
9/29/23 21:30 | 9/27/23 | ROIV | Roivant Sciences Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Gline Matthew | X0 | DO | CEO | M.d | 0 | 0.00 | 0 | 18 | 2 | 1,041 | D | | | | | | | | | | | | | | |
8/29/23 21:31 | 8/27/23 | ROIV | Roivant Sciences Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Gline Matthew | X0 | DO | CEO | M.d | 0 | 0.00 | 0 | 12 | 1 | 1,045 | D | | | | | | | | | | | | | | |
7/31/23 21:33 | 7/27/23 | ROIV | Roivant Sciences Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Gline Matthew | X0 | DO | CEO | M.d | 0 | 0.00 | 0 | 23 | 2 | 1,062 | D | | | | | | | | | | | | | | |
5/31/23 21:30 | 5/27/23 | ROIV | Roivant Sciences Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Gline Matthew | X0 | DO | CEO | M.d | 0 | 0.00 | 0 | 53 | 5 | 1,061 | D | | | | | | | | | | | | | | |
10/27/22 18:00 | 10/25/22 | ROIV | Roivant Sciences Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Gline Matthew | X0 | DO | CEO | S | -85 | 4.40 | 0 | -19 | -2 | 1,164 | D | | | | | | | | | | | | | | |
9/27/22 19:00 | 9/23/22 | ROIV | Roivant Sciences Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Gline Matthew | X0 | DO | CEO | S | -65 | 3.07 | 0 | -21 | -2 | 1,183 | D | | | | | | | | | | | | | | |
8/26/22 19:00 | 8/24/22 | ROIV | Roivant Sciences Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Gline Matthew | X0 | DO | CEO | S | -74 | 3.71 | 0 | -20 | -2 | 1,204 | D | | | | | | | | | | | | | | |
7/27/22 21:08 | 7/25/22 | ROIV | Roivant Sciences Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Gline Matthew | X0 | DO | CEO | S | -89 | 4.33 | 0 | -20 | -2 | 1,224 | D | | | | | | | | | | | | | | |
6/27/22 19:00 | 6/23/22 | ROIV | Roivant Sciences Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Gline Matthew | X0 | DO | CEO | S | -86 | 4.34 | 0 | -20 | -2 | 1,245 | D | | | | | | | | | | | | | | |
5/24/22 19:00 | 5/20/22 | ROIV | Roivant Sciences Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Gline Matthew | X0 | DO | CEO | S | -517 | 3.70 | 0 | -140 | -10 | 1,265 | D | | | | | | | | | | | | | | |
4/27/22 19:00 | 4/25/22 | ROIV | Roivant Sciences Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Gline Matthew | X0 | DO | CEO | S | -33 | 3.84 | 0 | -9 | -1 | 1,404 | D | | | | | | | | | | | | | | |
4/1/22 18:00 | 3/30/22 | ROIV | Roivant Sciences Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Gline Matthew | X0 | DO | CEO | S | -163 | 4.84 | 0 | -34 | -2 | 1,413 | D | | | | | | | | | | | | | | |
3/29/22 18:29 | 3/25/22 | ROIV | Roivant Sciences Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Gline Matthew | X0 | DO | CEO | S | -179 | 5.06 | 0 | -35 | -2 | 1,472 | D | | | | | | | | | | | | | | |
3/22/22 21:00 | 3/18/22 | ROIV | Roivant Sciences Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Gline Matthew | X0 | DO | CEO | S | -421 | 5.13 | 0 | -82 | -5 | 1,507 | D | | | | | | | | | | | | | | |
3/9/22 21:45 | 3/7/22 | ROIV | Roivant Sciences Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Gline Matthew | X0 | DO | CEO | S | -510 | 5.52 | 0 | -92 | -5 | 1,589 | D | | | | | | | | | | | | | | |